Search Results - "EBERLEIN, T. J"

Refine Results
  1. 1

    Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma by SINGER, S, CORSON, J. M, DEMETRI, G. D, HEALEY, E. A, MARCUS, K, EBERLEIN, T. J

    Published in Annals of surgery (01-02-1995)
    “…The authors identified prognostic factors relevant to clinical outcomes (especially survival) in truncal and retroperitoneal soft-tissue sarcoma. These results…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Retinoic acid receptor-independent mechanism of apoptosis of melanoma cells by the retinoid CD437 (AHPN) by Zhao, X, Demary, K, Wong, L, Vaziri, C, McKenzie, A B, Eberlein, T J, Spanjaard, R A

    Published in Cell death and differentiation (01-09-2001)
    “…Retinoic acid (RA) induces differentiation of S91 melanoma cells through activation of RA receptor (RAR)gamma without affecting cell viability. The novel…”
    Get full text
    Journal Article
  4. 4

    Breast and Ovarian Cancer-Specific Cytotoxic T Lymphocytes Recognize the Same HER2/Neu-Derived Peptide by Peoples, George E., Goedegebuure, Peter S., Smith, Roy, Linehan, David C., Yoshino, Ichiro, Eberlein, Timothy J.

    “…The identification of antigenic peptides presented on the tumor cell surface by HLA class I molecules and recognized by tumor-specific cytotoxic T lymphocytes…”
    Get full text
    Journal Article
  5. 5

    The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy by Schnitt, S J, Abner, A, Gelman, R, Connolly, J L, Recht, A, Duda, R B, Eberlein, T J, Mayzel, K, Silver, B, Harris, J R

    Published in Cancer (15-09-1994)
    “…The relationships among the involvement of tumor at the final margins of resection, the presence of an extensive intraductal component (EIC), and the risk of…”
    Get more information
    Journal Article
  6. 6

    Prospective evaluation of immediate reconstruction after mastectomy by EBERLEIN, T. J, CRESPO, L. D, SMITH, B. L, HERGRUETER, C. A, DOUVILLE, L, ERIKSSON, E

    Published in Annals of surgery (01-07-1993)
    “…The authors prospectively studied the impact of immediate breast reconstruction on patients undergoing mastectomy. Despite the advocation of a…”
    Get full text
    Journal Article
  7. 7

    Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study by Goedegebuure, P S, Douville, L M, Li, H, Richmond, G C, Schoof, D D, Scavone, M, Eberlein, T J

    Published in Journal of clinical oncology (01-08-1995)
    “…The objective of this study was to determine the tolerance and effect of moderate-dose recombinant human interleukin-2 (rHu IL-2) and tumor-infiltrating…”
    Get more information
    Journal Article
  8. 8

    Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand by v. Bernstorff, Wolfram, Spanjaard, Remco A., Chan, Allen K., Lockhart, Diane C., Sadanaga, Noriaki, Wood, Isabelle, Peiper, Matthias, Goedegebuure, Peter S., Eberlein, Timothy J.

    Published in Surgery (1999)
    “…Background: The Fas (APO-1/CD95) receptor/Fas ligand (FasR/FasL) system plays a key role in immune surveillance. We investigated the possibility of a tumor…”
    Get full text
    Journal Article
  9. 9

    Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma by SINGER, S, CORSON, J. M, GONIN, R, LABOW, B, EBERLEIN, T. J

    Published in Annals of surgery (01-02-1994)
    “…The authors sought to identify prognostic factors in the management of extremity soft tissue sarcoma. The surgical management of soft tissue sarcoma has…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Thoracic epidural anesthesia improves outcome after breast surgery by LYNCH, E.P, WELCH, K. J, CARABUENA, J. M, EBERLEIN, T. J

    Published in Annals of surgery (01-11-1995)
    “…The authors' objective was to compare the outcomes, including the incidence of nausea and vomiting and the time until discharge to home, of patients undergoing…”
    Get full text
    Journal Article
  12. 12

    Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer by Yoshino, I, Peoples, GE, Goedegebuure, PS, Maziarz, R, Eberlein, TJ

    Published in The Journal of immunology (1950) (01-03-1994)
    “…To study potential sources of tumor-associated Ags in human ovarian cancer, we have established two ovarian tumor cell lines (OvS1 and OvA2) from two ovarian…”
    Get full text
    Journal Article
  13. 13

    The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy by VICINI, F. A, EBERLEIN, T. J, WOOD, W, FOSTER, R. S, SILEN, W, CONNOLLY, J. L, RECHT, A, ABNER, A, SCHNITT, S. J, SILEN, W, HARRIS, J. R, ZEPPA, R, WALT, A. J

    Published in Annals of surgery (01-09-1991)
    “…The optimal extent of breast resection before irradiation for treatment of early breast cancer has not been defined. Increasing the size of the resection may…”
    Get full text
    Conference Proceeding Journal Article
  14. 14

    Current management of carcinoma of the breast by EBERLEIN, T. J

    Published in Annals of surgery (01-08-1994)
    “…An in-depth retrospective review of the multidisciplinary approach to the management of carcinoma of the breast was done. The author reviewed previous trials…”
    Get full text
    Journal Article
  15. 15

    HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer by Peoples, GE, Goedegebuure, PS, Andrews, JV, Schoof, DD, Eberlein, TJ

    Published in The Journal of immunology (1950) (15-11-1993)
    “…Tumor-associated lymphocytes (TAL) from the malignant ascites and tumor-infiltrating lymphocytes (TIL) from the solid tumor were isolated from six consecutive…”
    Get full text
    Journal Article
  16. 16

    Local secretion of IFN-gamma induces an antitumor response: comparison between T cells plus IL-2 and IFN-gamma transfected tumor cells by Sadanaga, N, Nagoshi, M, Lederer, J A, Joo, H G, Eberlein, T J, Goedegebuure, P S

    Published in Journal of immunotherapy (1997) (01-07-1999)
    “…Previously we described that the adoptive transfer of tumor-infiltrating lymphocytes (TIL) + interleukin-2 (IL-2) leads to eradication of established…”
    Get more information
    Journal Article
  17. 17

    Mechanisms of radiocolloid localization in sentinel node biopsy by Linehan, D C, Eberlein, T J

    Published in Annals of surgical oncology (01-03-2000)
    “…IntroductionCytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is an established treatment for pseudomyxoma peritonei resulting…”
    Get full text
    Journal Article
  18. 18

    Breast reconstruction by Noda, S, Eberlein, T J, Eriksson, E

    Published in Cancer (01-07-1994)
    “…Breast reconstruction after mastectomy is becoming more common despite the general trend toward breast conserving therapy with lumpectomy and radiation…”
    Get more information
    Journal Article
  19. 19

    T-cell recognition of ovarian cancer by Peoples, G E, Schoof, D D, Andrews, J V, Goedegebuure, P S, Eberlein, T J

    Published in Surgery (01-08-1993)
    “…The existence of a tumor-specific T-cell immune response to human malignant melanoma has been well documented. In contrast, the existence of tumor-specific…”
    Get more information
    Journal Article
  20. 20